ContraVac
706F Forest Street
Charlottesville, VA 22903 USA
phone: 434-984-9723
fax:
Symbol Private
Founded 0
Employees
www.contravac.com
Research Sector
Summary Description
ContraVac develops innovative diagnostics products for men who seek actionable information about their fertility health but wish to test themselves at home.
Management
Keywords
ContraVac

Comment | Printable Version | Jun. 19, 2008
If you work for ContraVac and want to update this profile, click here


Description
ContraVac develops products for male reproductive healthcare in cooperation with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia. ContraVac is dedicated to developing and commercializing research discoveries into innovative diagnostics for male reproductive health care.
Products / Services
ContraVacs family of SpermCheck products have been developed to meet the needs of millions of men who seek actionable information about their fertility health but wish to test themselves at home to avoid the indignities associated with traditional semen analysis.
Technology / Differentiation
ContraVacs platform technology is based on the ongoing research conducted at the Center for Contraceptive and Reproductive Health at the University of Virginia  where the discovery of sperm specific biomarkers and the subsequent development of specific antibody reagents directed toward these biomarkers, will be applied to various existing commercial diagnostic formats. These biomarkers (protein antigens) possess certain characteristics and properties that lend themselves to be used as valuable tools in diagnostic assays; they all are highly sperm specific (only expressed in mature sperm) and highly expressed (abundant). As a result, these biomarkers can be used in various standardized diagnostic formats such as lateral flow immunodiagnostic devices (similar to home pregnancy tests) and Elisa assays.
Status
SpermCheck Vasectomy will be commercially available in the Summer of 2008 and SpermCheck Fertility at the end of 2008.